Enanta Pharmaceuticals reported $12.57M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Acorda Therapeutics ACOR:US USD 23M 7.07M
Amgen AMGN:US USD 1.29B 40M
Anika Therapeutics ANIK:US USD 21.28M 8K
Arrowhead Research ARWR:US USD 32.74M 1.12M
AstraZeneca AZN:LN USD 3.35B 280M
Biocryst Pharmaceuticals BCRX:US USD 36.92M 1.1M
Biogen BIIB:US USD 563.3M 9.3M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Clovis Oncology CLVS:US USD 30.38M 2.21M
Enanta Pharmaceuticals ENTA:US USD 12.57M 360K
Gilead Sciences GILD:US USD 1.21B 144M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Halozyme Therapeutics HALO:US USD 34.07M 23.41M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Insmed INSM:US USD 75.58M 15.61M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Johnson & Johnson JNJ:US USD 6.09B 137M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Marinus Pharmaceuticals MRNS:US USD 13.39M 3.67M
Merk MRK:US USD 2.47B 13M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Novartis NOVN:VX USD 3.4B 185M
Novavax NVAX:US USD 122.88M 14.72M
Pfizer PFE:US USD 3.54B 345M
Ptc Therapeutics PTCT:US USD 80.12M 226K
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Vital Therapies VTL:US USD 3.58M 493K
YTE INCY:US USD 266.46M 13.18M